Trial Profile
A multicenter,open label,randomized controlled traial for the head-to-head comparison of minodronic acid hydroate and raloxifene hydrocloride
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2021
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary) ; Raloxifene (Primary)
- Indications Fracture; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms A-TOP/JOINT-04; JOINT-04
- 12 Oct 2018 Status changed from active, no longer recruiting to completed.
- 17 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Apr 2011 New trial record